Health
Research reveals underperformance of many Phase III oncology trials – News-Medical.Net
New research in the September 2021 issue of JNCCN-;Journal of the National Comprehensive Cancer Network finds that more than…
New research in the September 2021 issue of JNCCN-;Journal of the National Comprehensive Cancer Network finds that more than 80% of therapies tested in Phase III oncology trials did not achieve meaningful clinical benefit in prolonging survival. The researchers…
Continue Reading
-
General23 hours agoWedding guests shelter under tables as storm tears roof from historic Camboon Campdraft Hall
-
Business18 hours ago1 ASX dividend stock down 37% I’d buy right now
-
General12 hours agoNew York Marathon won by Benson Kipruto wins in classic photo finish, Eliud Kipchoge announces final tour
-
General23 hours agoInvestors and first home buyers flock to property market, driving up prices